FID prosigue su larga colaboración con Novo Nor...
Novo Nordisk launches once-a-week diabetes drug...
Novo Nordisk to test anti-obesity molecule in t...
Novo Nordisk A/S Sees Unusually Large Options V...
Novo Nordisk’s Global Commitment to Diabetes Ca...
Novo Nordisk - la compañia que trata la diabete...
Novo Nordisk submits diabetes pill for US approval
Novo Nordisk amplía sus fármacos contra la obes...
China OKs Novo Nordisk's Type-2 diabetes treatm...
Novo Nordisk Research Centre opens in Oxford | ...
Signal: Novo Nordisk market cap higher than Dan...
Is Novo Nordisk Stock a Buy After its Collapse?...
Novo Nordisk Logo Png
Novo Nordisk
Novo Nordisk Posts Record Growth as Demand For ...
NOVO NORDISK INC.: Novo Nordisk Launches Ozempi...
Novo Nordisk receives FDA approval for Wegovy™
Novo Nordisk's results are stunning - and it co...
Novartis' Sandoz dips on debut after lower than...
Novo Nordisk leaps on new obesity drug data | p...
Novo Nordisk experience big profit rise due to ...
First: Novo Nordisk India launches oral Semaglu...
Novo Nordisk hits all-time high as oral obesity...